Divalproex sodium and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Divalproex sodium (divalproex sodium), especially for people who are male, 60+ old, also take Lisinopril, and have Muscle spasticity.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Divalproex sodium. It is created by eHealthMe based on reports of 9,295 people who have side effects when taking Divalproex sodium from the FDA, and is updated regularly.

What is Divalproex sodium?

Divalproex sodium has active ingredients of divalproex sodium. It is often used in epilepsy. eHealthMe is studying from 9,483 Divalproex sodium users. Check the latest studies of Divalproex sodium.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,494 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

On Jul, 07, 2026

9,295 people reported to have side effects when taking Divalproex sodium.
Among them, 18 people (0.19%) have Visual acuity reduced.

Could Divalproex sodium cause Visual acuity reduced?

Among these 18 people:

What is the gender of people who have Visual acuity reduced when taking Divalproex sodium? *

female: 38.89 %
male: 61.11 %

What is the age of people who have Visual acuity reduced when taking Divalproex sodium? *

What are other drugs people take besides Divalproex sodium? *

What are other side effects people have besides Visual acuity reduced? *

Chest Pain: 8 people, 44.44%
Balance Disorder: 7 people, 38.89%
Stress And Anxiety: 7 people, 38.89%
Visual Impairment: 5 people, 27.78%
Heart Attack: 5 people, 27.78%
Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 4 people, 22.22%
Dental Fistula: 4 people, 22.22%
Dental Caries: 4 people, 22.22%
Joint Pain: 4 people, 22.22%
Loss Of Consciousness: 4 people, 22.22%

What are the existing conditions these people have? *

Sleep Disorder: 3 people, 16.67%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 16.67%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 16.67%
Hyperthyroidism (over activity of the thyroid gland): 2 people, 11.11%
Multiple Myeloma (cancer of the plasma cells): 2 people, 11.11%
High Blood Pressure: 2 people, 11.11%
Hypersensitivity: 2 people, 11.11%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 11.11%
Intraocular Pressure Increased: 2 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Divalproex sodium and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Divalproex sodium:

Divalproex sodium (9,483 reports)

Browse all side effects of Divalproex sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,494 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,887 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on divalproex sodium (the active ingredients of Divalproex sodium) and Divalproex sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.